Clinical Trial Update: Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis (PCT)

View source ↗

Summary

The trial evaluating procalcitonin as a diagnostic and monitoring biomarker for osteomyelitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteomyelitis

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Osteomyelitis | Status: COMPLETED